{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:20:30Z","timestamp":1794856830399,"version":"4.9.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.cpcardiol.2024.102791","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T17:18:41Z","timestamp":1723137521000},"page":"102791","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Global and regional prevalence and cardiovascular risk of primary aldosteronism: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"49","author":[{"given":"Miao","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiexiong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaogang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2024.102791_bib0001","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.7326\/0003-4819-66-6-1079","article-title":"Hypokalemia in the hypertensive patient, with observations on the incidence of primary aldosteronism","volume":"66","author":"Kaplan","year":"1967","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0002","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0003","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0004","doi-asserted-by":"crossref","unstructured":"Burrello J, Monticone S, Losano I, et al. Prevalence of Hypokalemia and Primary Aldosteronism in 5100 Patients Referred to a Tertiary Hypertension Unit. Hypertension. 2020;75:1025-1033.","DOI":"10.1161\/HYPERTENSIONAHA.119.14063"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0005","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.eprac.2020.10.007","article-title":"Prevalence, Subtype Classification, and Outcomes of Treatment of Primary Aldosteronism: A Prospective Study in China","volume":"27","author":"Xu","year":"2021","journal-title":"Endocr Pract"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0006","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/HJH.0b013e328360ddf6","article-title":"Prevalence of and risk factors for primary aldosteronism among patients with resistant hypertension in China","volume":"31","author":"Sang","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0007","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(08)60834-X","article-title":"Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study","volume":"371","author":"Douma","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0008","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1097\/HJH.0000000000002441","article-title":"Prevalence of primary aldosteronism and association with cardiovascular complications in patients with resistant and refractory hypertension","volume":"38","author":"Parasiliti-Caprino","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0009","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2020.02.052","article-title":"Primary Aldosteronism in Patients in China With Recently Detected Hypertension","volume":"75","author":"Xu","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0010","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.mce.2011.06.014","article-title":"Mineralocorticoid receptors in vascular function and disease","volume":"350","author":"McCurley","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0011","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1161\/01.HYP.0000123572.45556.a5","article-title":"Human endothelium: target for aldosterone","volume":"43","author":"Oberleithner","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0012","article-title":"Primary aldosteronism","volume":"377","author":"Choy","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0013","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/cphy.c130037","article-title":"Regulation of aldosterone synthesis and secretion","volume":"4","author":"Bollag","year":"2014","journal-title":"Compr Physiol"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0014","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","article-title":"Cardiac Fibrosis: The Fibroblast Awakens","volume":"118","author":"Travers","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0015","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1161\/STROKEAHA.120.033990","article-title":"Hypertension Management in Stroke Prevention: Time to Consider Primary Aldosteronism","volume":"52","author":"McCarthy","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0016","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0017","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0018","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2013-2805","article-title":"Long-term cardio- and cerebrovascular events in patients with primary aldosteronism","volume":"98","author":"Mulatero","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0019","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF03347840","article-title":"Vascular complications in patients with aldosterone producing adenoma in Japan: comparative study with essential hypertension. The Research Committee of Disorders of Adrenal Hormones in Japan","volume":"18","author":"Takeda","year":"1995","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0020","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0021","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/XEB.0000000000000054","article-title":"Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data","volume":"13","author":"Munn","year":"2015","journal-title":"Int J Evid Based Healthc"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0022","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0023","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(05)74868-6","article-title":"Potentially high prevalence of primary aldosteronism in a primary-care population","volume":"353","author":"Lim","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0024","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.jhh.1001013","article-title":"High prevalence of primary aldosteronism in the Tayside hypertension clinic population","volume":"14","author":"Lim","year":"2000","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0025","first-page":"2854","article-title":"Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore","volume":"85","author":"Loh","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0026","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-2002-23491","article-title":"Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism","volume":"110","author":"Trenkel","year":"2002","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0027","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0895-7061(02)02969-2","article-title":"High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives","volume":"15","author":"Rossi","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0028","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","article-title":"Primary aldosteronism and hypertensive disease","volume":"42","author":"Mosso","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0029","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1097\/00004872-200311000-00025","article-title":"High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients","volume":"21","author":"Stowasser","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0030","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/sj.jhh.1001554","article-title":"Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region","volume":"17","author":"Strauch","year":"2003","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0031","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1097\/00004872-200402001-00883","article-title":"Low prevalence of white-coat hypertension in subjects with resistant hypertension and hyperaldosteronism","volume":"22","author":"Calhoun","year":"2004","journal-title":"Journal of hypertension"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0032","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1291\/hypres.27.193","article-title":"Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan","volume":"27","author":"Omura","year":"2004","journal-title":"Hypertens Res"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0033","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.amjhyper.2005.01.002","article-title":"Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension","volume":"18","author":"Nishizaka","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0034","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1373\/clinchem.2004.041780","article-title":"Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity","volume":"51","author":"Schwartz","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0035","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0036","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1291\/hypres.30.111","article-title":"Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone\/renin ratio above 25 as a screening test","volume":"30","author":"Fogari","year":"2007","journal-title":"Hypertens Res"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0037","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1157\/13117734","article-title":"Prevalence of primary aldosteronism in hypertensive patients and its effect on the heart","volume":"61","author":"Morillas","year":"2008","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0038","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1590\/S0066-782X2009000100007","article-title":"Prevalence of primary hyperaldosteronism in a systemic arterial hypertension league","volume":"92","author":"Ribeiro","year":"2009","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0039","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/1470320310366581","article-title":"Renin-angiotensin-aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism","volume":"11","author":"Di Murro","year":"2010","journal-title":"Journal of the renin-angiotensin-aldosterone system : JRAAS"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0040","first-page":"399","article-title":"Prevalence of primary aldosteronism among bulgarian hypertensive patients","volume":"5","author":"Matrozova","year":"2010","journal-title":"Central European Journal of Medicine"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0041","first-page":"57","article-title":"Primary aldosteronism among newly diagnosed and untreated hypertensive patients in a Swedish primary care area","volume":"29","author":"Westerdahl","year":"2011","journal-title":"Scand J Prim Health Care"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0042","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1161\/HYPERTENSIONAHA.111.179788","article-title":"Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension","volume":"58","author":"Pedrosa","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0043","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1472-6823-12-17","article-title":"Unilateral adrenal hyperplasia is a usual cause of primary hyperaldosteronism. Results from a Swedish screening study","volume":"12","author":"Sigurjonsdottir","year":"2012","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0044","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s12020-012-9609-z","article-title":"Effect of age on aldosterone\/renin ratio (ARR) and comparison of screening accuracy of ARR plus elevated serum aldosterone concentration for primary aldosteronism screening in different age groups","volume":"42","author":"Yin","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1530\/EJE-11-1013","article-title":"Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies","volume":"167","author":"Hannemann","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0046","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/jhh.2013.32","article-title":"Clinical characteristics of patients with resistant hypertension: the RESIST-POL study","volume":"27","author":"Florczak","year":"2013","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0047","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/eci.12286","article-title":"Primary aldosteronism in hypertensive patients: clinical implications and target therapy","volume":"44","author":"Papanastasiou","year":"2014","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0048","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/HJH.0b013e3283656b54","article-title":"Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronism","volume":"32","author":"Jansen","year":"2014","journal-title":"J Hypertens"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0049","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ancard.2016.04.016","article-title":"Causes of secondary hypertension in the young population: A monocentric study","volume":"65","author":"Noilhan","year":"2016","journal-title":"Ann Cardiol Angeiol"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0050","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0051","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.3399\/bjgp18X694589","article-title":"Prevalence of primary aldosteronism in primary care: a cross-sectional study","volume":"68","author":"K\u00e4yser","year":"2018","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0052","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/cen.14409","article-title":"High prevalence and a long delay in the diagnosis of primary aldosteronism among patients with young-onset hypertension","volume":"94","author":"Alam","year":"2021","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0053","doi-asserted-by":"crossref","first-page":"408","DOI":"10.5694\/mja2.51438","article-title":"Detecting primary aldosteronism in Australian primary care: a prospective study","volume":"216","author":"Libianto","year":"2022","journal-title":"Med J Aust"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0054","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0055","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/HYPERTENSIONAHA.112.197111","article-title":"Observational study mortality in treated primary aldosteronism: the German Conn's registry","volume":"60","author":"Reincke","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0056","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/HYPERTENSIONAHA.113.01316","article-title":"Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism","volume":"62","author":"Rossi","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0057","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","article-title":"Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study","volume":"62","author":"Savard","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0058","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/HJH.0000000000001251","article-title":"Plasma aldosterone level within the normal range is less associated with cardiovascular and cerebrovascular risk in primary aldosteronism","volume":"35","author":"Murata","year":"2017","journal-title":"J Hypertens"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0059","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1161\/HYPERTENSIONAHA.117.10263","article-title":"Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan","volume":"71","author":"Ohno","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0060","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/HYPERTENSIONAHA.117.10596","article-title":"Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term","volume":"71","author":"Rossi","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0061","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1210\/jc.2016-1472","article-title":"Study Heterogeneity and Estimation of Prevalence of Primary Aldosteronism: A Systematic Review and Meta-Regression Analysis","volume":"101","author":"K\u00e4yser","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0062","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1152\/ajpheart.00113.2003","article-title":"Aldosteronism: an immunostimulatory state precedes proinflammatory\/fibrogenic cardiac phenotype","volume":"285","author":"Gerling","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0063","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)64454-9","article-title":"Aldosterone-induced inflammation in the rat heart : role of oxidative stress","volume":"161","author":"Sun","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0064","doi-asserted-by":"crossref","first-page":"e15985","DOI":"10.1097\/MD.0000000000015985","article-title":"Cardiovascular risk in primary aldosteronism: A systematic review and meta-analysis","volume":"98","author":"Wu","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0065","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0895-7061(02)03199-0","article-title":"Aldosterone-induced cardiac damage: focus on blood pressure independent effects","volume":"16","author":"Schmidt","year":"2003","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.cpcardiol.2024.102791_bib0066","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.HYP.28.5.785","article-title":"Vascular hypertrophy and remodeling in secondary hypertension","volume":"28","author":"Rizzoni","year":"1996","journal-title":"Hypertension"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280624004274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280624004274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T05:25:50Z","timestamp":1726723550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280624004274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":66,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0146280624004274"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2024.102791","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global and regional prevalence and cardiovascular risk of primary aldosteronism: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2024.102791","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102791"}}